TELOMERASE-PEPTIDE VACCINE TOGETHER WITH GEMCITABINE IN ADVANCED PANCREATIC CANCER PATIENTS

被引：0
|
作者：
Staff, C. E. B. [1 ]
Mozaffari, F. M. [1 ]
Liljefors, M. [1 ]
Mosolits, S. [1 ]
Frodin, J. [1 ]
Choudhury, A. [1 ]
Mellstedt, H. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [21] A phase III randomized trial of chemoimmunotherapy comprising gemcitabine and capecitabine with or without telomerase vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer.
    Middleton, Gary William
    Valle, Juan W.
    Wadsley, Jonathan
    Propper, David
    Coxon, Fareeda Y.
    Ross, Paul J.
    Madhusudan, Srinivasan
    Roques, Tom
    Cunningham, David
    Corrie, Philippa
    Greenhalf, William
    Shaw, Victoria
    Cox, Trevor F.
    Silcocks, Paul
    Nanson, Gemma
    Neoptolemos, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18)
  • [22] A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment
    Chen, Zheling
    Zhang, Shanshan
    Han, Ning
    Jiang, Jiahong
    Xu, Yunyun
    Ma, Dongying
    Lu, Lantian
    Guo, Xiaojie
    Qiu, Min
    Huang, Qinxue
    Wang, Huimin
    Mo, Fan
    Chen, Shuqing
    Yang, Liu
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [23] Phase I clinical trial with VEGFR2-epitope peptide and gemcitabine for patients with advanced pancreatic cancer
    Yamaue, H.
    Miyazawa, M.
    Ohsawa, R.
    Tani, M.
    Kawai, M.
    Hirono, S.
    Ina, S.
    Tsunoda, T.
    Nakamura, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Phase I Clinical Trial Using Peptide Vaccine for Human Vascular Endothelial Growth Factor Receptor 2 in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer
    Miyazawa, M.
    Tani, M.
    Kawai, M.
    Hirono, S.
    Okada, K.
    Shimizu, A.
    Kitahata, Y.
    Yamaue, H.
    PANCREAS, 2014, 43 (08) : 1392 - 1392
  • [25] Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer
    Miyazawa, Motoki
    Ohsawa, Ryuji
    Tsunoda, Takuya
    Hirono, Seiko
    Kawai, Manabu
    Tani, Masaji
    Nakamura, Yusuke
    Yamaue, Hiroki
    CANCER SCIENCE, 2010, 101 (02): : 433 - 439
  • [26] Phase 1 Trial of Wilms Tumor 1 (WT1) Peptide Vaccine and Gemcitabine Combination Therapy in Patients With Advanced Pancreatic or Biliary Tract Cancer
    Kaida, Miho
    Morita-Hoshi, Yuriko
    Soeda, Atsuko
    Wakeda, Takako
    Yamaki, Yuni
    Kojima, Yasushi
    Ueno, Hideki
    Kondo, Shunsuke
    Morizane, Chigusa
    Ikeda, Masafumi
    Okusaka, Takuji
    Takaue, Yoichi
    Heike, Yuji
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (01) : 92 - 99
  • [27] Nabpaclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering hyperbilirubenemia
    Pelzer, U.
    Wislocka, L.
    Bischoff, S.
    Juehling, A.
    Sinn, M.
    Striefler, J.
    Klein, F.
    Ghadjar, P.
    Bahra, M.
    Doerken, B.
    Riess, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 260 - 260
  • [28] Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer
    Boeck, Stefan
    Wilkowski, Ralf
    Bruns, Christiane J.
    Issels, Rolf D.
    Schulz, Christoph
    Moosmann, Nicolas
    Laessig, Dorit
    Haas, Michael
    Golf, Alexander
    Heinemann, Volker
    ONCOLOGY, 2007, 73 (3-4) : 221 - 227
  • [29] Gemcitabine Combined With Uracil-Tegafur in Patients With Advanced Pancreatic Cancer
    Coskun, Ugur
    Alkis, Necati
    Celenkoglu, Gokhan
    Buyukberber, Sueleyman
    Ozkan, Metin
    Camci, Celalettin
    Uner, Aytug
    Er, Ozlem
    Aslan, Ulkue Yalcintas
    Sevinc, Alper
    Tokluoglu, Saadet
    Ozturk, Banu
    Yildiz, Ramazan
    Benekli, Mustafa
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2009, 101 (08) : 761 - 764
  • [30] Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer
    Mitry, Emmanuel
    Hammel, Pascal
    Deplanque, Gael
    Mornex, Francoise
    Levy, Philippe
    Seitz, Jean-Francois
    Moussy, Alain
    Kinet, Jean-Pierre
    Hermine, Olivier
    Rougier, Philippe
    Raymond, Eric
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (02) : 395 - 403
12345